Skip to main content
AIOBIO Co., Ltd. logo

AIOBIO Co., Ltd. — Investor Relations & Filings

Ticker · 447690 ISIN · KR7447690009 KO Manufacturing
Open in API
Filings indexed 88 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country KR South Korea
Listing KO 447690

About AIOBIO Co., Ltd.

https://www.aiobio.com/

AIOBIO Co., Ltd. is a medical device company specializing in advanced dental care solutions. The company develops and manufactures diagnostic tools and platforms based on its proprietary Biofluorescence-Led Intelligent Screening System (BLISS) technology. Its product portfolio includes imaging devices that provide instant visual analysis for the early detection of oral health issues. AIOBIO's core offering is the LINKDENS platform, an integrated system that connects dental clinics and patients. Powered by AI-driven diagnostics, instant imaging analysis, and remote patient monitoring, LINKDENS streamlines clinical workflows, enhances diagnostic accuracy, and fosters a connected dental care experience for both professionals and patients.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2025.12)
Regulatory Filings
2026-05-04 Korean
[기재정정]사업보고서 (2025.12)
Regulatory Filings
2026-05-04 Korean
[기재정정]감사보고서제출
Regulatory Filings
2026-04-30 Korean
정기주주총회결과 (제15기)
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is titled “정기주주총회 결과” and provides detailed voting outcomes for each AGM resolution (approval of financial statements, director elections, compensation limits, share option grants, etc.), including vote percentages and whether each item was passed. This is exactly the official declaration of shareholder vote results at an AGM, matching the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 85% confidence The document is a formal notification to the Financial Services Commission/KRX regarding the appointment (and reappointment) of an outside director (‘사외이사’). It details changes in board composition, including names, terms, and background of the new outside director. This falls squarely under announcements of changes in the company’s board of directors or senior management. Therefore, it should be classified as Board/Management Information (MANG).
2026-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 85% confidence The document is a formal disclosure to the Korean Financial Services Commission/Korea Exchange regarding the grant of stock options (“주식매수선택권 부여”) by issuing new shares (“보통주 신주 발행 교부”). It details share quantities, exercise prices, vesting schedules, valuation methods, and recipients. This constitutes an announcement of a new share issuance and capital change under corporate law. Therefore, the correct category is Share Issue/Capital Change (SHA).
2026-03-31 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.